{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:25:52Z","timestamp":1759332352851},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2010,3,12]],"date-time":"2010-03-12T00:00:00Z","timestamp":1268352000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1038\/eye.2010.14","type":"journal-article","created":{"date-parts":[[2010,3,12]],"date-time":"2010-03-12T10:48:53Z","timestamp":1268390933000},"page":"1315-1319","source":"Crossref","is-referenced-by-count":19,"title":["Use of pegaptanib for recurrent and non-clearing vitreous haemorrhage in proliferative diabetic retinopathy"],"prefix":"10.1038","volume":"24","author":[{"given":"D","family":"Hornan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Edmeades","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Lochhead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,12]]},"reference":[{"issue":"4","key":"BFeye201014_CR1","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/S0161-6420(80)35232-9","volume":"87","author":"MC Ziemianski","year":"1980","unstructured":"Ziemianski MC, McMeel JW, Franks EP . Natural history of vitreous hemorrhage in diabetic retinopathy. Ophthalmology 1980; 87 (4): 306\u2013312.","journal-title":"Ophthalmology"},{"issue":"7","key":"BFeye201014_CR2","first-page":"477","volume":"97","author":"CM Yang","year":"1998","unstructured":"Yang CM . Surgical treatment for diabetic retinopathy: 5-Year experience. J Formos Med Assoc 1998; 97 (7): 477\u2013484.","journal-title":"J Formos Med Assoc"},{"issue":"7","key":"BFeye201014_CR3","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1097\/00006982-200510000-00001","volume":"25","author":"CR Gonzales","year":"2005","unstructured":"Gonzales CR, VEGF Inhibition Study in Ocular Neovascularization (VISION) Clinical Trial Group. Enhanced efficacy associated with early treatment of neovascular age-related macular degeneration with pegaptanib sodium: An exploratory analysis. Retina 2005; 25 (7): 815\u2013827.","journal-title":"Retina"},{"issue":"1","key":"BFeye201014_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ophtha.2005.10.012","volume":"113","author":"AP Adamis","year":"2006","unstructured":"Adamis AP, Altaweel M, Bressler NM, Cunningham ET, Davis MD, Goldbaum M et al. Changes in retinal neovascularization after pegaptanib (macugen) therapy in diabetic individuals. Ophthalmology 2006; 113 (1): 23\u201328.","journal-title":"Ophthalmology"},{"issue":"6","key":"BFeye201014_CR5","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1001\/archopht.124.6.920","volume":"124","author":"MG Krzystolik","year":"2006","unstructured":"Krzystolik MG, Filippopoulos T, Ducharme JF, Loewenstein JI . Pegaptanib as an adjunctive treatment for complicated neovascular diabetic retinopathy. Arch Ophthalmol 2006; 124 (6): 920\u2013921.","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"BFeye201014_CR6","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.ophtha.2006.10.009","volume":"114","author":"AG Bansal","year":"2007","unstructured":"Bansal AG, Narayanan R, Majji AB, Thomas R . Neovascular changes after pegaptanib in diabetics. Ophthalmology 2007; 114 (3): 615\u2013616.","journal-title":"Ophthalmology"},{"issue":"6","key":"BFeye201014_CR7","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/j.1755-3768.2008.01391.x","volume":"87","author":"E Mendrinos","year":"2009","unstructured":"Mendrinos E, Donati G, Pournaras CJ . Rapid and persistent regression of severe new vessels on the disc in proliferative diabetic retinopathy after a single intravitreal injection of pegaptanib. Acta Ophthalmol 2009; 87 (6): 683\u2013684.","journal-title":"Acta Ophthalmol"},{"issue":"10","key":"BFeye201014_CR8","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/j.ophtha.2005.06.007","volume":"112","author":"ET Cunningham","year":"2005","unstructured":"Cunningham ET, Adamis AP, Altaweel M, Aiello LP, Bressler NM, D\u2019Amico DJ et al. A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology 2005; 112 (10): 1747\u20131757.","journal-title":"Ophthalmology"},{"issue":"12","key":"BFeye201014_CR9","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1136\/bjo.2007.132597","volume":"92","author":"LJ Singerman","year":"2008","unstructured":"Singerman LJ, Masonson H, Patel M, Adamis AP, Buggage R, Cunningham E et al. Pegaptanib sodium for neovascular age-related macular degeneration: Third-Year safety results of the VEGF inhibition study in ocular neovascularisation (VISION) trial. Br J Ophthalmol 2008; 92 (12): 1606\u20131611.","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"BFeye201014_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2353\/ajpath.2007.061237","volume":"171","author":"K Nishijima","year":"2007","unstructured":"Nishijima K, Ng YS, Zhong L, Bradley J, Schubert W, Jo N et al. Vascular endothelial growth factor-a is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am J Pathol 2007; 171 (1): 53\u201367.","journal-title":"Am J Pathol"},{"issue":"1","key":"BFeye201014_CR11","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3928\/15428877-20090101-04","volume":"40","author":"E Chen","year":"2009","unstructured":"Chen E, Hsu J, Park CH . Acute visual acuity loss following intravitreal bevacizumab for diabetic macular edema. Ophthalmic Surg Lasers Imaging 2009; 40 (1): 68\u201370.","journal-title":"Ophthalmic Surg Lasers Imaging"},{"issue":"11","key":"BFeye201014_CR12","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1016\/j.ophtha.2007.05.057","volume":"114","author":"AS Neubauer","year":"2007","unstructured":"Neubauer AS, Kook D, Haritoglou C, Priglinger SG, Kampik A, Ulbig MW et al. Bevacizumab and retinal ischemia. Ophthalmology 2007; 114 (11): 2096.","journal-title":"Ophthalmology"},{"issue":"8","key":"BFeye201014_CR13","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/j.1755-3768.2008.01175.x","volume":"86","author":"KS Kim","year":"2008","unstructured":"Kim KS, Chang HR, Song S . Ischaemic change after intravitreal bevacizumab (avastin) injection for macular oedema secondary to non-ischaemic central retinal vein occlusion. Acta Ophthalmol 2008; 86 (8): 925\u2013927.","journal-title":"Acta Ophthalmol"},{"issue":"7","key":"BFeye201014_CR14","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1097\/IAE.0b013e3181754209","volume":"28","author":"EJ Chung","year":"2008","unstructured":"Chung EJ, Roh MI, Kwon OW, Koh HJ . Effects of macular ischemia on the outcome of intravitreal bevacizumab therapy for diabetic macular edema. Retina 2008; 28 (7): 957\u2013963.","journal-title":"Retina"},{"issue":"11","key":"BFeye201014_CR15","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/eye.2008.253","volume":"22","author":"D Mitry","year":"2008","unstructured":"Mitry D, Schmoll C, Hegde V, Borooah S, Singh J, Bennett H . Use of pegaptanib in the treatment of vitreous haemorrhage in idiopathic retinal vasculitis. Eye 2008; 22 (11): 1449\u20131450.","journal-title":"Eye"},{"issue":"2","key":"BFeye201014_CR16","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ajo.2008.04.028","volume":"146","author":"CM Yang","year":"2008","unstructured":"Yang CM, Yeh PT, Yang CH, Chen MS . Bevacizumab pretreatment and long-acting gas infusion on vitreous clear-up after diabetic vitrectomy. Am J Ophthalmol 2008; 146 (2): 211\u2013217.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"BFeye201014_CR17","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1442-9071.2008.01805.x","volume":"36","author":"J Yeoh","year":"2008","unstructured":"Yeoh J, Williams C, Allen P, Buttery R, Chiu D, Clark B et al. Avastin as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy: a prospective case series. Clin Experiment Ophthalmol 2008; 36 (5): 449\u2013454.","journal-title":"Clin Experiment Ophthalmol"},{"issue":"1","key":"BFeye201014_CR18","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/sj.eye.6702983","volume":"23","author":"K Ishikawa","year":"2009","unstructured":"Ishikawa K, Honda S, Tsukahara Y, Negi A . Preferable use of intravitreal bevacizumab as a pretreatment of vitrectomy for severe proliferative diabetic retinopathy. Eye 2009; 23 (1): 108\u2013111.","journal-title":"Eye"},{"issue":"3","key":"BFeye201014_CR19","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/00006982-200603000-00004","volume":"26","author":"RF Spaide","year":"2006","unstructured":"Spaide RF, Fisher YL . Intravitreal bevacizumab (avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina 2006; 26 (3): 275\u2013278.","journal-title":"Retina"},{"issue":"6","key":"BFeye201014_CR20","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/j.1600-0420.2007.01042.x","volume":"86","author":"AM Minnella","year":"2008","unstructured":"Minnella AM, Savastano CM, Ziccardi L, Scupola A, Falsini B, Balestrazzi E . Intravitreal bevacizumab (avastin) in proliferative diabetic retinopathy. Acta Ophthalmol 2008; 86 (6): 683\u2013687.","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"BFeye201014_CR21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/sj.eye.6702980","volume":"23","author":"JF Arevalo","year":"2009","unstructured":"Arevalo JF, Wu L, Sanchez JG, Maia M, Saravia MJ, Fernandez CF et al. Intravitreal bevacizumab (avastin) for proliferative diabetic retinopathy: 6-months follow-up. Eye 2009; 23 (1): 117\u2013123.","journal-title":"Eye"},{"issue":"12","key":"BFeye201014_CR22","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1007\/s00417-008-0914-4","volume":"246","author":"S Moradian","year":"2008","unstructured":"Moradian S, Ahmadieh H, Malihi M, Soheilian M, Dehghan MH, Azarmina M . Intravitreal bevacizumab in active progressive proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 2008; 246 (12): 1699\u20131705.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"BFeye201014_CR23","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1038\/eye.2008.179","volume":"23","author":"R Krishnan","year":"2009","unstructured":"Krishnan R, Goverdhan S, Lochhead J . Intravitreal pegaptanib in severe proliferative diabetic retinopathy leading to the progression of tractional retinal detachment. Eye 2009; 23 (5): 1238\u20131239.","journal-title":"Eye"},{"issue":"6","key":"BFeye201014_CR24","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/sj.eye.6703036","volume":"22","author":"P Tranos","year":"2008","unstructured":"Tranos P, Gemenetzi M, Papandroudis A, Chrisafis C, Papadakos D . Progression of diabetic tractional retinal detachment following single injection of intravitreal avastin. Eye 2008; 22 (6): 862.","journal-title":"Eye"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/eye201014.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye201014","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye201014.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T02:00:14Z","timestamp":1711332014000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye201014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,12]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["BFeye201014"],"URL":"https:\/\/doi.org\/10.1038\/eye.2010.14","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,12]]}}}